Last 48 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
LeMaitre Vascular, Inc.'s quarterly P/E stands at 40.1x, down 8.2% year-over-year. EV/EBITDA has expanded 9.8% YoY to 37.7x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 37.28 | 40.14 | 29.82 | 29.17 | 34.60 | 43.70 | 47.01 | 47.39 | 39.56 | 38.58 | 37.34 | 41.27 | 46.72 |
| — | -8.2% | -36.6% | -38.5% | -12.5% | +13.3% | +25.9% | +14.8% | -15.3% | -19.0% | -18.9% | -18.6% | -34.4% | |
| P/S Ratio | 8.57 | 9.44 | 7.23 | 8.74 | 7.40 | 8.02 | 9.47 | 9.67 | 8.37 | 7.05 | 6.52 | 6.46 | 7.54 |
| — | +17.7% | -23.7% | -9.6% | -11.6% | +13.8% | +45.2% | +49.8% | +11.1% | +15.8% | +4.4% | -10.5% | +25.9% | |
| P/B Ratio | 5.47 | 6.18 | 4.73 | 5.63 | 5.24 | 5.53 | 6.26 | 6.41 | 5.85 | 4.89 | 4.28 | 4.24 | 5.32 |
| — | +11.9% | -24.3% | -12.1% | -10.4% | +13.1% | +46.2% | +51.0% | +10.0% | +16.9% | +12.1% | -1.5% | +36.2% | |
| P/FCF | 28.74 | 51.06 | 21.78 | 20.15 | 25.08 | 62.74 | 40.15 | 42.17 | 60.34 | 101.87 | 33.66 | 28.43 | 41.50 |
| — | -18.6% | -45.8% | -52.2% | -58.4% | -38.4% | +19.3% | +48.3% | +45.4% | -94.7% | -62.9% | -30.5% | +36.3% | |
| EV / EBITDA | 29.33 | 37.65 | 23.56 | 25.02 | 27.41 | 34.28 | 37.02 | 34.01 | 27.83 | 26.31 | 25.09 | 26.43 | 32.01 |
| — | +9.8% | -36.4% | -26.4% | -1.5% | +30.3% | +47.5% | +28.7% | -13.1% | -6.1% | -9.0% | -20.4% | +4.9% | |
| EV / EBIT | 33.83 | — | 23.38 | 24.03 | 26.59 | 33.50 | 32.11 | 40.28 | 30.08 | 29.31 | 25.42 | 33.32 | 39.14 |
| — | — | -27.2% | -40.3% | -11.6% | +14.3% | +26.3% | +20.9% | -23.1% | -16.3% | -22.3% | -27.2% | +38.6% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
LeMaitre Vascular, Inc.'s operating margin was 26.7% in Q1 2026, down 2.5 pp QoQ and up 5.6 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 28.6% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin expanded 5.1% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.5% | 72.7% | 71.7% | 75.3% | 70.0% | 69.2% | 69.3% | 67.8% | 68.9% | 68.6% | 68.1% | 65.0% | 64.0% |
| — | +5.1% | +3.5% | +11.0% | +1.7% | +0.9% | +1.8% | +4.3% | +7.6% | +4.5% | +7.0% | +1.2% | -3.1% | |
| Operating Margin | 27.2% | 26.7% | 29.2% | 33.3% | 25.1% | 21.1% | 23.1% | 24.0% | 25.7% | 22.2% | 20.9% | 19.4% | 18.9% |
| — | +26.6% | +26.6% | +38.7% | -2.4% | -5.0% | +10.5% | +23.9% | +36.5% | +32.7% | +22.7% | +22.9% | +37.3% | |
| Net Margin | 23.1% | 23.6% | 24.2% | 28.4% | 21.5% | 18.4% | 20.1% | 20.3% | 21.2% | 18.5% | 17.3% | 15.8% | 16.2% |
| — | +28.1% | +20.4% | +39.9% | +1.3% | -0.5% | +15.9% | +28.4% | +31.0% | +44.1% | +26.0% | +13.2% | +93.6% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.8% | 3.9% | 4.0% | 4.7% | 3.9% | 3.2% | 3.3% | 3.4% | 3.8% | 3.3% | 2.9% | 2.6% | 2.9% |
| — | +21.9% | +20.6% | +36.7% | +3.0% | -1.4% | +15.9% | +30.7% | +29.7% | +46.4% | +35.8% | +24.7% | +113.0% | |
| ROA | 9.9% | 2.5% | 2.6% | 3.0% | 2.4% | 2.0% | 2.4% | 3.0% | 3.3% | 2.8% | 2.5% | 2.3% | 2.5% |
| — | +26.7% | +6.6% | -1.9% | -26.3% | -29.6% | -3.2% | +32.5% | +30.6% | +46.1% | +35.4% | +25.2% | +112.6% | |
| ROIC | 9.7% | 2.4% | 2.6% | 2.9% | 2.4% | 1.9% | 2.3% | 3.1% | 3.5% | 3.0% | 2.6% | 2.4% | 2.6% |
| — | +26.3% | +11.0% | -6.2% | -32.7% | -37.2% | -11.5% | +26.4% | +37.0% | +37.1% | +33.0% | +35.3% | +50.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
LeMaitre Vascular, Inc.'s Debt/EBITDA ratio is 10.7x, up from 8.7x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 13.2% YoY to 14.32x, tightening the short-term liquidity position. Debt/Equity has declined for 6 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.47 | 0.47 | 0.47 | 0.49 | 0.51 | 0.53 | 0.55 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| — | -12.5% | -14.3% | +785.0% | +789.6% | +771.3% | +758.9% | -5.4% | -2.7% | +1.7% | +3.6% | -8.6% | -11.2% | |
| Debt / EBITDA | 2.37 | 10.68 | 8.66 | 8.10 | 9.89 | 12.21 | 12.11 | 1.18 | 1.10 | 1.32 | 1.51 | 1.46 | 1.43 |
| — | -12.6% | -28.5% | +588.1% | +800.9% | +822.0% | +702.3% | -19.3% | -23.0% | -17.9% | -15.8% | -26.1% | -31.8% | |
| Current Ratio | 12.89 | 14.32 | 12.89 | 13.58 | 13.96 | 16.49 | 13.14 | 7.74 | 8.36 | 7.57 | 6.51 | 6.28 | 6.75 |
| — | -13.2% | -1.9% | +75.4% | +66.9% | +117.9% | +101.8% | +23.3% | +23.9% | +9.8% | +2.0% | -3.9% | +6.4% | |
| Quick Ratio | 10.95 | 12.20 | 10.95 | 11.45 | 12.09 | 14.23 | 11.31 | 5.79 | 6.14 | 5.54 | 4.76 | 4.51 | 4.85 |
| — | -14.3% | -3.2% | +97.6% | +97.1% | +157.0% | +137.6% | +28.5% | +26.5% | +14.2% | +3.6% | -4.5% | +6.4% | |
| Interest Coverage | 15.50 | 13.67 | 16.64 | 18.40 | 14.91 | 12.04 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LMAT stock.
LeMaitre Vascular, Inc.'s current P/E is 37.3x. The average P/E over the last 4 quarters is 33.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
LeMaitre Vascular, Inc.'s current operating margin is 27.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking LeMaitre Vascular, Inc.'s business trajectory between earnings reports.